Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability’ by Yiran Zhu et al.

Yiran Zhu; Bingluo Zhou; Xinyang Hu; Shilong Ying; Qiyin Zhou; Wenxia Xu; Lifeng Feng; Tianlun Hou; Xian Wang; Liyuan Zhu; Hongchuan Jin

doi:10.1002/ctm2.70106

Yiran Zhu , Bingluo Zhou , Xinyang Hu , Shilong Ying , Qiyin Zhou , Wenxia Xu , Lifeng Feng , Tianlun Hou , Xian Wang , Liyuan Zhu , Hongchuan Jin

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (11) : e70106

PDF

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (11) : e70106 DOI: 10.1002/ctm2.70106

ERRATUM

Author information +

History +

PDF

Cite this article

Download citation ▾

Yiran Zhu, Bingluo Zhou, Xinyang Hu, Shilong Ying, Qiyin Zhou, Wenxia Xu, Lifeng Feng, Tianlun Hou, Xian Wang, Liyuan Zhu, Hongchuan Jin. Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability’ by Yiran Zhu et al.. Clinical and Translational Medicine, 2024, 14(11): e70106 DOI:10.1002/ctm2.70106

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.